Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Abingdon Health opens its US manufacturing hub in Madison, Wisconsin

On 25 September 2026, Abingdon Health announced the official opening of its manufacturingFacilityin Madison, Wisconsin. The event took the form of a ribbon-cutting ceremony attended by company executives and local and state officials.

Ankur Sharma | 28 September 2026

Why Hikma Pharmaceuticals Is Now a FTSE 250 Stock - and What It Means for Investors

TheBusinessdid not collapse. Hikma remains profitable and cash-generative, with more than $3bn of annual revenue. What changed was the market's view of how fast it can grow, especially in US injectables. It was not promoted back in the September 2026 review.

Ankur Sharma | 25 September 2026

Why Did Covalon Technologies (TSXV:COV) Edge Up 0.246% on 24 September 2026?

Covalon operates in the healthcare technology space, with itsBusinessfocused on technologies and products designed to address wound care, infection prevention and other medical applications. For investors following smaller healthcare companies, the key question is whether commercial expansion and product adoption can eventually translate into …

Manish Choudhary | 25 September 2026

Why CVS Group (LSE:CVSG) Is Watching the Vet Market Regulatory Review Closely

That review has now reached its end point. The CMA published its final report on 24 March 2026 and its final order on 22 September 2026, with the first measures due to apply to larger practice groups from 23 December 2026. Two days after …

Divya Sood | 25 September 2026

How Genus (LSE:GNS) Is Bringing Gene-Edited Pigs Closer to Market

The US, the market that matters most, is further back in the queue. The Food and Drug Administration approved the gene edit in April 2025, and Canada followed in January 2026. Genus has said that successful commercialisation in North America also requires approvals in …

Divya Sood | 25 September 2026

How BioPharma Credit (LSE:BPCR) Generates Income From Life-Sciences Lending

The model has been busy in 2026. Since March the trust has announced new loans to Zenas BioPharma, Mineralys Therapeutics, Idorsia, Kestra Medical and the ARCHIMED-backedAcquisitionof Esperion, while also closing out its long-running LumiraDx exposure. That flurry of deals matters because the company ended …

Divya Sood | 25 September 2026

Why Did ImmuPharma Plc LSE:IMC Fall 4.40% Amid a softer tone across London-listed biotech shares?

ImmuPharma Plc — LSE:IMC closed 4.40% lower on24 September 2026, with the shares at 3.81p after a fall of 0.18p on the day.

Ankur Sharma | 24 September 2026

Why Did Poolbeg Pharma Plc LSE:POLB Fall 4.56% Amid a softer tone across London-listed biotech shares?

Poolbeg Pharma Plc — LSE:POLB closed 4.56% lower on24 September 2026, with the shares at 8.64p after a fall of 0.41p on the day.

Ankur Sharma | 24 September 2026

Why Did RUA Life Sciences Plc LSE:RUA Fall 0.36% Amid a softer tone across London-listed medical polymer shares?

RUA Life Sciences Plc — LSE:RUA closed 0.36% lower on24 September 2026, with the shares at 27.90p after a fall of 0.10p on the day.

Ankur Sharma | 24 September 2026

Why Was AOTI, Inc. LSE:AOTI Unchanged Amid mixed trading across London-listed medical device shares?

AOTI, Inc. — LSE:AOTI closed unchanged on24 September 2026, with the shares at 130.00p and no change on the day.

Ankur Sharma | 24 September 2026
Support

Hi! How can we help you today?

Loading…